Statin use for primary prevention of CVD was associated with lower risk for COVID-19 hospitalizations and in-hospital deaths, according to findings from a cohort study published in the Journal of the American Heart Association.“Statins are now known to be beneficial in primary prevention, decreasing all-cause mortality, cardiovascular disease, coronary heart disease and stroke,” Kim
Healio and Cardiology Today have compiled the most-read cardiology news of June 2022.Readers were most interested in improving the messaging surrounding aspirin; the midterm CV safety of men’s hormone therapy; promotion of hands-only CPR to increase use and improve cardiac arrest outcomes; and more.
Continuous subcutaneous infusion of foslevodopa/foscarbidopa was safe and improved motor complications in patients with advanced Parkinson’s disease, according to data presented at the European Academy of Neurology Congress 2022. “ABBV-951 (foslevodopa/foscarbidopa) is a solution of levodopa and carbidopa prodrugs for continuous subcutaneous infusion being investigated for the
Impaired exercise ventilatory efficiency above the upper limit of normal was associated with a greater dyspnea burden and low peak VO2 among never smokers and smokers with or without COPD, researchers reported.“Activity-related dyspnea and exercise limitation . are common, even in mild COPD, and are associated with poor health status and increased mortality. The traditional focus of
With the U.S. Supreme Court’s decision to overturn Roe v. Wade, health care providers are questioning how to help patients legally navigate reproductive care. After the ruling, several states moved to immediately ban abortions through so-called “trigger laws.” Jessie Hill, JD, the associate dean for research and faculty development and a professor at the Case Western University